62 results
Page 3 of 4
424B3
v8q0om m7c
10 Apr 15
Prospectus supplement
12:00am
10-K
onlec7i
25 Mar 15
Annual report
12:00am
424B3
21qw3 hdvzw1s
26 Feb 15
Prospectus supplement
12:00am
8-K
EX-99.1
2nw2turl
5 Feb 15
Recro Pharma to Present at the 17th Annual BIO CEO & Investor
12:00am
8-K
EX-99.1
vtv5p393
3 Feb 15
Recro Pharma Enters into Common Stock Purchase Agreement with Aspire Capital
12:00am
8-K
EX-99.2
1ku6 m62n
10 Nov 14
Recro Pharma Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
umy65lfkz
10 Nov 14
Recro Pharma Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
md9w6sl
30 Oct 14
Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery
12:00am
8-K
EX-99.1
b8ytdlf
9 Sep 14
Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference
12:00am
8-K
EX-99.2
t43ayejg8vg vz
9 Sep 14
Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference
12:00am
8-K
EX-99.1
2pekfr
4 Sep 14
Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN
12:00am
8-K
EX-99.1
d2mev
12 Aug 14
Recro Pharma Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
yrxa4
1 Jul 14
Other Events
12:00am
8-K
EX-99.1
oxqnh2qzxendn0lbnkr
17 Jun 14
Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery
12:00am
8-K
EX-99.1
u8286tu2vq0ox zui45g
1 Apr 14
This presentation includes forward-looking statements within the meaning of Section
12:00am
8-K
EX-99.1
xoo8cdq94v4 hjfkx9
13 Mar 14
Recro Pharma Announces New Board Members
12:00am
424B4
ls5na1cvdju765
7 Mar 14
Prospectus supplement with pricing info
12:00am